Corticosteroids for community-acquired pneumonia: are we still there?

M. Pereira Catarata (Coimbra, Portugal), G. Gonçalves (Coimbra, Portugal), M. Matos (Coimbra, Portugal), A. Ferreira (Coimbra, Portugal)

Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Session: Severe pneumonia: epidemiology, mechanisms and treatment
Session type: Thematic Poster
Number: 2915
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Pereira Catarata (Coimbra, Portugal), G. Gonçalves (Coimbra, Portugal), M. Matos (Coimbra, Portugal), A. Ferreira (Coimbra, Portugal). Corticosteroids for community-acquired pneumonia: are we still there?. 2915

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are corticosteroids useful in community-acquired pneumonia?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Corticosteroids for community-acquired pneumonia: a critical view of the evidence
Source: Eur Respir J 2016; 48: 984-986
Year: 2016


Corticosteroids and community-acquired pneumonia
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007


Corticosteroids in severe pneumonia
Source: Eur Respir J 2008; 32: 259-264
Year: 2008



Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016



Community-acquired pneumonia: severity and antibiotic treatments
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

What is pneumonia?
Source: Breathe, 17 (3) 210087; 10.1183/20734735.0087-2021
Year: 2021



Should steroids be used in community-acquired pneumonia? Pro argument
Source: International Congress 2017 – Controversies in community-acquired pneumonia: a pro and con debate
Year: 2017


Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006



Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004

Low-dose corticosteroids during severe community-acquired pneumonia: end of the story
Source: Eur Respir J 2015; 45: 305-307
Year: 2015


Community-acquired pneumonia: treatment failure and complications
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!
Source: Eur Respir J 2008; 31: 1150-1152
Year: 2008


Should macrolides be given to all patients with community-acquired pneumonia? Pro argument
Source: International Congress 2017 – Controversies in community-acquired pneumonia: a pro and con debate
Year: 2017


Community-acquired pneumonia associated with COPD : a special entity ?
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


COPD: what is the frequency and impact of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008